Showing results (431-440 of 782) with videos related to

Sort By:
Pageof 79
The Journal of Small Animal Practice|July 28, 2020
Mast cell tumours in dogs less than 12 months of age: a multi-institutional retrospective studyK Rigas, D Biasoli, G Polton, et al.
Emerging Infectious Diseases|February 21, 2025
Burkholderia pseudomallei Sequence Type 46 Transmission from Asia to AustraliaElla M Meumann, Mirjam Kaestli, Jessica R Webb, et al.
Clinical and Experimental Nephrology|November 20, 2024
The role of C-reactive protein-to-albumin ratio as a prognostic biomarker in patients hospitalized for cardiorenal syndromePanagiotis Theofilis, Aikaterini Vordoni, Paschalis Karakasis, et al.
Molecular Medicine Reports|August 2, 2011
Structure-activity relationship study of novel anticancer aspirin-based compoundsStancy Joseph, Ting Nie, Liqun Huang, et al.
Biochemistry|April 25, 1995
Prostaglandin E2 down-regulates the expression of HLA-DR antigen in human colon adenocarcinoma cell linesP Arvind, E D Papavassiliou, G J Tsioulias, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 23, 2014
Pegylation improves the pharmacokinetics and bioavailability of small-molecule drugs hydrolyzable by esterases: a study of phospho-IbuprofenGeorge Mattheolabakis, Chi C Wong, Yu Sun, et al.
International Journal of Oncology|July 31, 2012
Topical phospho-sulindac (OXT-328) is effective in the treatment of non-melanoma skin cancerKa Wing Cheng, George Mattheolabakis, Chi C Wong, et al.
International Journal of Molecular Sciences|December 23, 2023
Mitochondrial p38 Mitogen-Activated Protein Kinase: Insights into Its Regulation of and Role in LONP1-Deficient NematodesEirini Taouktsi, Eleni Kyriakou, Evangelia Voulgaraki, et al.
Frontiers in Drug Delivery|June 19, 2026
Phosphosulindac (OXT-328) restores the suppressed corneal sensitivity in rabbits with dry eye disease: therapeutic implicationsWei Huang, Ziyi Wen, Konstantinos Tourmouzis, et al.
Pageof 79